Product Name:N'-(7-Chloro-4-methyl-1,3-benzothiazol-2-yl)-N,N-diethylethane-1,2-diamine
IUPAC Name:7-chloro-N-[2-(diethylamino)ethyl]-4-methyl-1,3-benzothiazol-2-amine
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM561744-100mg | in stock | ǑƛȐ |
|
| CM561744-250mg | in stock | ƃȐŵ |
|
| CM561744-1g | 3-4 Weeks | ȯŞƛƥ |
|
|
|||
| Product Overview |
N'-(7-chloro-4-methyl-1,3-benzothiazol-2-yl)-N,N-diethylethane-1,2-diamine is a compound that has gained significant attention in the scientific community due to its potential therapeutic applications. This compound is commonly referred to as CME-1, and it belongs to the family of benzothiazole derivatives. |
| Physical Properties |
One of the limitations of CME-1 is its poor solubility in aqueous solutions, which can make it difficult to administer in vivo. |
| Chemical Properties |
One of the advantages of CME-1 is its high potency and selectivity. It has been shown to have a low toxicity profile and is well-tolerated in animal models. Additionally, CME-1 is stable and can be easily synthesized in large quantities. Additionally, more research is needed to fully understand the mechanism of action and potential side effects of CME-1. |
| Synthesis and Application |
CME-1 has been extensively studied for its potential therapeutic applications. It has been shown to exhibit anti-cancer, anti-inflammatory, and neuroprotective properties. In cancer research, CME-1 has been found to inhibit the growth of various cancer cell lines, including breast, lung, and colon cancer. Inflammation is a common factor in many diseases, and CME-1 has been shown to reduce inflammation in animal models. Additionally, CME-1 has been found to protect neurons from oxidative stress and improve cognitive function in animal models of Alzheimer's disease. |
| Storage and Handling |
It has been shown to exhibit anti-cancer, anti-inflammatory, and neuroprotective properties. The synthesis of CME-1 involves the reaction of 7-chloro-4-methyl-1,3-benzothiazol-2-amine with diethylamine in the presence of ethanol. The mechanism of action of CME-1 is not fully understood, but it is believed to involve the inhibition of various signaling pathways. CME-1 has several advantages, including its high potency and selectivity, but also has limitations, such as its poor solubility in aqueous solutions. Future directions for research on CME-1 include its potential as a therapeutic agent for cancer and neurodegenerative diseases. |
Search 
+86 21 5895 0110 
